Jeena Sikho Lifecare Limited — PPTs, 08-02-2026: Investor Presentation

Jeena Sikho Lifecare delivered a robust Q3FY26, with Revenue from Operations surging 92% YoY to ₹221.66 Cr. Profit After Tax jumped 405% YoY to ₹66.73 Cr, showcasing strong financial performance. EBITDA margin remained healthy at 45%, reflecting operational efficiency. Growth was driven by solid contributions from both Ayurveda Healthcare Services and Products, with Medicine being the largest revenue contributor. The company also saw significant increases in patient volumes across OPD, IPD, and video consultations.

Key growth drivers include ongoing capacity expansion, with 475+ beds currently under development, and successful product diversification, supported by new launches. The company recently added 510 operational beds, expanding its reach. Management commentary emphasizes sustained volume expansion and a strengthening pan-India presence. Looking ahead, JSLL plans to launch the Jeena Sikho Health Card to enhance customer value. The company remains focused on strategic expansion and a differentiated product portfolio for long-term value creation.